The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
HER2-enriched subtype and ERBB2 mRNA as predictors of pathological complete response following trastuzumab and lapatinib without chemotherapy in early-stage HER2-positive breast cancer: A combined analysis of TBCRC006/023 and PAMELA trials.
 
Aleix Prat
Consulting or Advisory Role - NanoString Technologies (Inst)
Research Funding - NanoString Technologies (Inst)
 
Carmine De Angelis
No Relationships to Disclose
 
Tomás Pascual
No Relationships to Disclose
 
Carolina Gutierrez
No Relationships to Disclose
 
Antonio Llombart-Cussac
No Relationships to Disclose
 
Tao Wang
No Relationships to Disclose
 
Javier Cortes
Stock and Other Ownership Interests - MedSIR
Honoraria - Celgene; Eisai; Novartis; Pfizer; Roche
Consulting or Advisory Role - AstraZeneca; Biothera; Celgene; Cellestia Biotech; Merus; Roche
 
Brent Neil Rexer
Research Funding - Lilly (Inst)
 
Jamunarani Veeraraghavan
No Relationships to Disclose
 
Andres Forero-Torres
Speakers' Bureau - Seagen
Research Funding - Daiichi Sankyo (Inst); Genentech/Roche (Inst); Gilead Sciences (Inst); Immunomedics (Inst); Novartis (Inst); Oncothyreon (Inst); Pfizer (Inst); Seagen (Inst); Syndax (Inst); TRACON Pharma (Inst)
 
Antonio C. Wolff
Research Funding - Myriad Genetics (Inst); Pfizer (Inst)
Patents, Royalties, Other Intellectual Property - Antonio Wolff has been named as inventor on one or more issued patents or pending patent applications relating to methylation in breast cancer, and has assigned his rights to JHU, and participates in a royalty sharing agreement with JHU.
 
Serafin Morales
No Relationships to Disclose
 
Ian E. Krop
No Relationships to Disclose
 
Anne Clarisse Pavlick
No Relationships to Disclose
 
Begona Bermejo
No Relationships to Disclose
 
Susan G. Hilsenbeck
No Relationships to Disclose
 
Mafalda Oliveira
Consulting or Advisory Role - Roche/Genentech
Research Funding - AstraZeneca (Inst); Genentech/Roche (Inst)
 
Rachel Schiff
Research Funding - AstraZeneca
Travel, Accommodations, Expenses - Lilly
 
C. Kent Osborne
Stock and Other Ownership Interests - Genetex
Consulting or Advisory Role - AstraZeneca; Genentech/Roche; Ventana Medical Systems
Patents, Royalties, Other Intellectual Property - Royalties for co editor of Diseases of the Breast
Expert Testimony - AstraZeneca
Travel, Accommodations, Expenses - Ventana Medical Systems
 
Mothaffar F. Rimawi
Consulting or Advisory Role - Celgene